Skip to main content
. 2014 Sep;58(9):5024–5035. doi: 10.1128/AAC.02470-13

TABLE 4.

Properties of sVISA strains compared with those of other MRSA strains with different susceptibilities to vancomycin

Straina Category of vancomycin susceptibility Colony sizeb Doubling time (min) Vancomycin MIC (mg/liter) evaluated by Etest after incubation time (h) ofc:
rpoB genotyped
No. of LC/total no. of colonies (%) observed after the indicated time (days) of serial passagee
48 72 96 120 144 Amino acid change Nucleotide change 1f 2 3 7
1-4d sVISA PC 64.8 6 8 8 8 8 WT 32/44 (72.7) NT NT NT
1-5d sVISA PC 70.7 6 8 8 8 8 WT 488/490 (99.6) NT NT NT
2-6d sVISA PC 106.6 8 12 12 16 16 WT 6/45 (13.3) NT NT NT
3-4d sVISA PC 123.8 8 12 12 16 16 WT 6/66 (9.1) NT NT NT
4-4d sVISA PC 123.8 8 12 12 12 12 G744R GGA→AGA 217/231 (93.9) NT NT NT
4-5d sVISA PC 68.6 8 8 8 12 12 WT 56/74 (75.7) NT NT NT
5-4d sVISA SC 60.2 8 12 12 12 12 WT 7/51 (13.7) NT NT NT
5-5d sVISA PC 58.3 8 12 12 12 12 S746F TCT→TTT 17/6.3 × 104 NT NT
6-4d sVISA PC 71.5 24 24 32 32 32 WT 2/6.8 × 106 NT NT
11-6d sVISA PC 111.8 8 16 16 16 16 WT 330/335 (98.5) NT NT NT
12-5d sVISA PC 66 8 12 12 12 12 WT 50/51 (98.0) NT NT NT
14-4d sVISA PC 64.2 8 8 8 8 8 WT 13/2.3× 104 NT NT NT
16-4d sVISA PC 61.9 6 8 8 8 8 WT 47/47 (100)
17-4df sVISA PC 123.8 8 12 12 12 12 WT 4/5.2 × 104
17-6d sVISA PC 87.7 6 8 8 12 12 S746F TCT→TTT 4/43 (9.3) NT NT NT
18-4d sVISA PC 153.9 6 12 12 12 12 G977V GGT→GTG 25/1,410 (1.8) NT NT NT
18-5d sVISA PC 144.4 6 12 12 12 12 WT 2/1.4 × 104 NT NT NT
18-6df sVISA PC 182.4 4 4 6 6 8 WT 3/320 (0.9)
19-4d sVISA PC 141.5 8 12 16 24 24 WT 3/1.0× 104 NT NT
19-5d sVISA PC 63 8 12 12 12 12 WT 2/361 (0.5) NT NT NT
20-4d sVISA PC 64.8 12 24 24 24 24 WT 7/41 (17.0) NT NT NT
20-6d sVISA PC 77.3 8 8 8 8 8 WT 2/2,600 NT NT NT
21-4d sVISA PC 83.5 6 12 12 12 12 H929T CAT→TAT 14/2.6× 105 NT NT
22-4d sVISA SC 59.2 8 12 12 12 12 WT 3/5,100 NT NT NT
24-4d sVISA SC 58.2 8 8 8 8 8 WT 2/5,100 NT NT NT
25-4d sVISA PC 80.6 8 8 12 12 12 H929T CAT→TAT 2/640 (0.3) NT NT
Mu3 hVISA LC 36.9 3 3 3 3 3 WT NT NT NT NT
Mu50 VISA LC 37.1 12 12 12 12 12 H481Y CAT→TAT NT NT NT NT
6R-P sVISA PC 62.2 12 16 16 16 16 R512P CGT→CCT 3/1.0× 107 8/93 (8.6) 8/312 (41.0) 65/65 (100)
L1 hVISA LC 38.2 3 3 3 3 3 P512L CCT→CTT NT NT NT NT
L2 hVISA LC 39.7 3 4 4 4 4 P512S CCT→TCT NT NT NT NT
L3 VISA LC 36.9 4 6 6 6 6 P512H CCT→CAT NT NT NT NT
ΔIP VSSA LC 26.7 1 1 1.5 1.5 1.5 WT NT NT NT NT
ΔIPrpoB(R512P) hVISA SC 41.2 4 4 4 4 4 R512P CGT→CCT 2/4.9× 105 NT
H14 pre-hVISAg SC 28.3 3 3 3 3 3 WT NT
H14rpoB(R512P) VISA PC 45.2 8 8 12 12 12 R512P CGT→CCT 2/3.4 × 104 NT NT
a

The first number in the name of the sVISA strains denotes the culture tube from which the strain was isolated. The suffix denotes the day of appearance of the strain as a visible colony.

b

Observed at 20 h after streaking of the strain on BHI agar plate without vancomycin. LC, large colony; PC, pinpoint colony; SC, small colony.

c

If the colony size of the strain was heterogeneous, the smaller colony was picked for the test.

d

Entire ORF of rpoB gene was sequenced. The Mu3 rpoB sequence was referred to as the wild-type sequence. The underlined base is the changed nucleotide. WT, wild type.

e

Day 1, the starting culture before propagation; NT, not tested; −, large colonies were not observed (<1 × 108).

f

The strain seems to have been converted to VISA by a mutation(s). It may not be regarded as sVISA because of its rather stable phenotype throughout the drug-free propagation.

g

Pre-hVISA, a VSSA strain whose vancomycin-resistant subpopulation does not reach the level of hVISA; i.e., the frequency of the subpopulations of cells that can grow on the plate containing 4 mg/liter of vancomycin is >1 × 10−7 but <1 × 10−6 (see Fig. 2C).